Muller & Phipps (India) Limited share price
BSE: MULLER
Key numbers
- Market cap
- ₹ 12.9 Cr
- Current price
- ₹ 206.60
- 52-week high / low
- ₹ 264 / 188
- Stock P/E
- -
- Book value
- ₹ -33.3
- Dividend yield
- 0.00%
- ROCE
- -2.3%
- ROE
- 2.4%
- Debt to equity
- -0.36
- Sales growth (3 yrs)
- 12.9%
- Profit growth (3 yrs)
- -
- 1-year return
- -20.5%
About Muller & Phipps (India) Limited
Muller & Phipps (India) Limited markets and distributes over the counter medical preparation and home care products in India. The company sells medicated dental cream, gel, and gum astringent products under the Cavisan brand; skincare products under the Cavidine and Nixoderm brand name; cosmetics and toiletries, medicated preparations, and food products. It markets its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. The Muller & Phipps (India) Limited is a subsidiary of Development Holding Asia Ltd.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 1 | 2 | 1 | 2 | 1 |
| Operating profit | -0 | -0 | -0 | -0 | -0 |
| Net profit | 1 | -0 | -0 | -0 | 0 |
| EPS (₹) | 11.16 | -0.50 | -6.18 | -5.25 | 1.83 |
Peers in Pharmaceutical Retailers
Data for information only, not investment advice. Prices end of day.